Breaking News, Collaborations & Alliances

Catalent and Stirling Ultracold Enter Cold Chain Partnership

To establish energy-efficient cold chain capabilities for biologics and emerging modalities.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Catalent, a global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Stirling Ultracold, an innovative developer and manufacturer of ultra-low temperature (ULT) freezers for life science and biopharma research, have formed a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.   The growth o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters